Amanda Mather

1.8k total citations
22 papers, 804 citations indexed

About

Amanda Mather is a scholar working on Surgery, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Amanda Mather has authored 22 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 8 papers in Nephrology and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Amanda Mather's work include Diabetes Treatment and Management (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Amanda Mather is often cited by papers focused on Diabetes Treatment and Management (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Renal Transplantation Outcomes and Treatments (4 papers). Amanda Mather collaborates with scholars based in Australia, United Kingdom and United States. Amanda Mather's co-authors include Carol A. Pollock, Usha Panchapakesan, Muralikrishna Gangadharan Komala, Harshini Mudaliar, Simon Gross, Josephine M. Forbes, Chunling Huang, Sylvie Shen, W J Monafo and A.H. Filipovich and has published in prestigious journals such as The Lancet, PLoS ONE and The FASEB Journal.

In The Last Decade

Amanda Mather

21 papers receiving 789 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Amanda Mather 506 274 270 234 77 22 804
Ryo Kodera 372 0.7× 170 0.6× 188 0.7× 138 0.6× 60 0.8× 16 648
Nobuo Kajitani 340 0.7× 168 0.6× 161 0.6× 127 0.5× 54 0.7× 10 640
Chenzhong Li 287 0.6× 174 0.6× 133 0.5× 160 0.7× 45 0.6× 20 605
Liru Qiu 229 0.5× 236 0.9× 209 0.8× 245 1.0× 47 0.6× 32 712
Mako Yasuda‒Yamahara 225 0.4× 246 0.9× 152 0.6× 178 0.8× 34 0.4× 24 694
Joaquim Calado 461 0.9× 453 1.7× 325 1.2× 151 0.6× 55 0.7× 31 824
Yoshiki Higashijima 198 0.4× 362 1.3× 113 0.4× 164 0.7× 32 0.4× 24 729
Yuri Nishino 441 0.9× 202 0.7× 131 0.5× 162 0.7× 53 0.7× 28 912
Junna Yamaguchi 136 0.3× 213 0.8× 97 0.4× 176 0.8× 28 0.4× 16 620
Yuichi Takashi 217 0.4× 313 1.1× 115 0.4× 362 1.5× 21 0.3× 51 890

Countries citing papers authored by Amanda Mather

Since Specialization
Citations

This map shows the geographic impact of Amanda Mather's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Mather with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Mather more than expected).

Fields of papers citing papers by Amanda Mather

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Mather. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Mather. The network helps show where Amanda Mather may publish in the future.

Co-authorship network of co-authors of Amanda Mather

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Mather. A scholar is included among the top collaborators of Amanda Mather based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Mather. Amanda Mather is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Lone, Emma, et al.. (2023). Subsequent COVID-19 Prophylaxis in COVID-19 Associated Glomerulopathies. Vaccines. 11(7). 1152–1152.
2.
O’Connell, Rachel, et al.. (2022). Bisphosphonates and bone mineral density in patients with end-stage kidney disease and renal transplants: A 15-year single-centre experience. Bone Reports. 16. 101178–101178. 4 indexed citations
3.
Coorey, Craig P., Elaine Phua, Angela Chou, Yvonne Shen, & Amanda Mather. (2022). Anti-GBM Disease after Oxford-AstraZeneca ChAdOx1 nCoV-19 Vaccination: A Report of Two Cases. Case Reports in Nephrology and Dialysis. 12(3). 234–237. 5 indexed citations
4.
Plas, Willemijn Y. van der, Anton F. Engelsman, Amanda Mather, et al.. (2018). Treatment strategy of end stage renal disease-related hyperparathyroidism before, during, and after the era of calcimimetics. Surgery. 165(1). 135–141. 4 indexed citations
5.
Komala, Muralikrishna Gangadharan & Amanda Mather. (2014). Empagliflozin for the treatment of Type 2 diabetes. Expert Review of Clinical Pharmacology. 7(3). 271–279. 7 indexed citations
6.
Komala, Muralikrishna Gangadharan, Simon Gross, Harshini Mudaliar, et al.. (2014). Inhibition of Kidney Proximal Tubular Glucose Reabsorption Does Not Prevent against Diabetic Nephropathy in Type 1 Diabetic eNOS Knockout Mice. PLoS ONE. 9(11). e108994–e108994. 62 indexed citations
7.
8.
Panchapakesan, Usha, Simon Gross, Muralikrishna Gangadharan Komala, et al.. (2013). Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?. PLoS ONE. 8(2). e54442–e54442. 241 indexed citations
9.
Komala, Muralikrishna Gangadharan, Usha Panchapakesan, Carol A. Pollock, & Amanda Mather. (2012). Sodium glucose cotransporter 2 and the diabetic kidney. Current Opinion in Nephrology & Hypertension. 22(1). 113–119. 43 indexed citations
10.
Panchapakesan, Usha, Amanda Mather, & Carol A. Pollock. (2012). Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease. Clinical Science. 124(1). 17–26. 46 indexed citations
11.
Mather, Amanda & Carol A. Pollock. (2011). Glucose handling by the kidney. Kidney International. 79(120). S1–S6. 285 indexed citations
12.
Mather, Amanda & Carol A. Pollock. (2010). Renal glucose transporters: novel targets for hyperglycemia management. Nature Reviews Nephrology. 6(5). 307–311. 47 indexed citations
13.
Mather, Amanda, Xinming Chen, Stella McGinn, et al.. (2008). High glucose induced endothelial cell growth inhibition is associated with an increase in TGFβ1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway. The International Journal of Biochemistry & Cell Biology. 41(3). 561–569. 4 indexed citations
14.
Monafo, W J, Stephen H. Polmar, Steven Neudorf, Amanda Mather, & A.H. Filipovich. (1992). A hereditary immunodeficiency characterized by CD8+ T lymphocyte deficiency and impaired lymphocyte activation. Clinical & Experimental Immunology. 90(3). 390–393. 25 indexed citations
15.
MacLeod, Alison M., Keith N. Stewart, Amanda Mather, et al.. (1987). Noncytotoxic antibodies and renal transplant outcome. A prospective study.. PubMed. 44(6). 840–2. 4 indexed citations
16.
17.
Power, David A., Amanda Mather, Alison M. MacLeod, Thomas Lind, & G. R. D. Catto. (1986). Maternal antibodies to paternal B-lymphocytes in normal and abnormal pregnancy. American Journal of Reproductive Immunology. 10(1). 1 indexed citations
18.
Power, David A., Amanda Mather, Alison M. MacLeod, T. Lind, & G. R. D. Catto. (1986). Maternal Antibodies to Paternal B‐Lymphocytes in Normal and Abnormal Pregnancy. American Journal Of Reproductive Immunology. 10(1). 10–13. 6 indexed citations
19.
MacLeod, Alison M., G. R. D. Catto, Amanda Mather, et al.. (1985). BENEFICIAL ANTIBODIES IN RENAL-TRANSPLANTATION DEVELOPING AFTER BLOOD-TRANSFUSION - EVIDENCE FOR HLA LINKAGE. Transplantation Proceedings. 17(1). 1057–1058. 3 indexed citations
20.
MacLeod, Alison M., Amanda Mather, J Engeset, et al.. (1984). SELECTION OF RENAL-TRANSPLANT RECIPIENTS USING THE EA INHIBITION ASSAY - A FURTHER EVALUATION. Kidney International. 26(4). 644–644. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryo Kodera Breakdown of academic impact, for papers by Nobuo Kajitani Breakdown of academic impact, for papers by Chenzhong Li Breakdown of academic impact, for papers by Liru Qiu Breakdown of academic impact, for papers by Mako Yasuda‒Yamahara Breakdown of academic impact, for papers by Joaquim Calado Breakdown of academic impact, for papers by Yoshiki Higashijima Breakdown of academic impact, for papers by Yuri Nishino Breakdown of academic impact, for papers by Junna Yamaguchi Breakdown of academic impact, for papers by Yuichi Takashi
Rankless by CCL
2026